Magnetics Business & Technology - September/October 2019 - 7

FEATURE ARTICLE
100 people, the majority of which work there and at its other main
office in Eden Prairie, MN.
In depressed patients, electrical activity in certain areas of the
brain is reduced. Its Horizon system uses a focused electromagnetic coil to rapidly pulse a magnetic field to the targeted area of
the brain. This induces a small electrical current which stimulates
the targeted brain cells into activity, gradually increasing brain
activity back to a normal level. With a range of treatment protocols available in one system, Magstim gives practitioners the
flexibility to tailor their treatments for patients without the need to
change equipment.

In June, Magstim made another step forward when it launched
what it says is the first TMS navigation system specifically developed for the clinical market. Used with its Horizon system, the
company's new StimGuide provides precise and consistent coil
positioning in the treatment of major depressive disorder. The
3D navigation system aligns four distinct parameters to guide
clinicians to a precise target area for treatment, reducing any
potential variability in treatment and improving confidence and
consistency in the delivery of the TMS therapy.

In March, Magstim received FDA clearance to include intermittent Theta Burst Stimulation (iTBS) as a treatment for major
depressive disorder with its Horizon systems.

This clearance allows Magstim to market the 3-minute iTBS
protocol in the US now. It is already available in the UK and EU.
Clinicians have options to deliver treatments with the standard
repetitive Transcranial Magnetic Stimulation (rTMS), which takes
37.5 minutes, accelerated TMS at 19 minutes, and iTBS, which
takes just three minutes per treatment. Horizon was designed
with a proprietary energy recovery system to ensures consistency throughout the treatment with no pulse amplitude decay no
matter the protocol, a feature which the company says is unique.
The system is equipped with a versatile E-z Cool Coil which has
a longer pulse width that is optimized for patient comfort and has
been shown to be more tolerable for patients.

StimGuide was developed to provide a solution for clinical
centers that do not have access or the resources to provide
pre-treatment MRIs for patients. It offers the benefits of 3D
navigation without the expense and complexity associated with
more complicated navigation technology. It provides an option
to a one-dimensional contact sensor enabling a solution that can
leapfrog a cap and measuring method or contact sensor technology and provides precise and repeatable
coil positioning, said Krinke.
"I am convinced that StimGuide will improve
patient care because it ensures reliable
placement over the intended treatment target providing confidence to experienced and
new TMS treaters. It accurately measures
the distance of the coil from the intended
target as well as rotation and pitch ensuring
every pulse train is delivered in the optimal
coil position."
Other products from MagStim include a variety of coils, and its Rapid family of research
equipment which is compatible with the full
range of Magstim coils and has the ability to
connect an EMG module suitable for highfrequency repetitive protocols for both cortical and peripheral
stimulation.

Lothar Krinke, MagStim
Group CEO

"I am pleased that we can now market
the full capabilities of the Horizon Performance platform," commented Lothar
Krinke, MagStim Group CEO. "We want
to provide innovative systems that allow
clinicians and researchers to customize
and personalize treatment for patients,
and this clearance is another step in that
direction."

www.MagneticsMag.com

MagStim coil

MagStim's Rapid system for research

September/October 2019 * Magnetics Business & Technology

http://www.MagneticsMag.com

Magnetics Business & Technology - September/October 2019

Table of Contents for the Digital Edition of Magnetics Business & Technology - September/October 2019